Conference Coverage

VIDEO: New genetic research could identify Alzheimer’s therapy targets


 

At AAIC 2014

References

COPENHAGEN – The National Institutes of Health recently awarded $24 million to eight academic centers to analyze the human genome and identify genes that either increase the risk of Alzheimer’s disease or have a protective effect.

It’s a very exciting time in Alzheimer’s disease genetics, said Marilyn Miller, Ph.D., program director of the National Institute of Aging’s Genetics of Alzheimer’s Disease, Tau, and Hormone Research portfolios in the division of neuroscience.

In a video interview at the Alzheimer’s Association International Conference 2014, Dr. Miller explains the ongoing research and the implications for potential therapies.

Alzheimer’s genetics research resources:

The Alzheimer’s Disease Sequencing Project.

The NIA Genetics of Alzheimer’s Disease Data Storage Site.

The National Plan to Address Alzheimer’s Disease.

The National Human Genome Research Institute.

nmiller@frontlinemedcom.com

On Twitter @naseemmiller

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Do biomarkers for Alzheimer’s disease have utility in everyday practice?
MDedge Psychiatry
Frontotemporal dementia and its variants: What to look for
MDedge Psychiatry
Poor cardiovascular health predicted cognitive impairment
MDedge Psychiatry
Poor sleep is linked to cortical amyloid burden
MDedge Psychiatry
Physician-assisted suicide and changing state laws
MDedge Psychiatry
Smelling test makes progress in identifying preclinical Alzheimer’s
MDedge Psychiatry
Cerebral microbleeds’ depth may reveal dementia type
MDedge Psychiatry
ADHD drug works by stimulating brain’s motivation-reward system
MDedge Psychiatry
Rising projection of Alzheimer’s cases stems mainly from better reporting
MDedge Psychiatry
Alzheimer’s may be declining in U.S. and Germany
MDedge Psychiatry